Roche Says Actemra-Remdesivir Trial Fails to Cut Hospital Stays Roche Says Actemra-Remdesivir Trial Fails to Cut Hospital Stays

Swiss drugmaker Roche said on Thursday adding its drug Actemra to Gilead Sciences ' Veklury medication, also called remdesivir, did not reduce hospital stays for patients with severe COVID-19 pneumonia.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news